Sanofi to Pay Novavax Up to $1.2 Billion to License Vaccine Tech, Co-Develop New Products. Novavax agreed to license its ...
QuidelOrtho's new CEO started this week and joined investors during the local diagnostic company's first-quarter earnings ...
Novavax on Friday erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion ...
Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to ...
CLEVELAND, Ohio – The number of new COVID-19 cases in Ohio has fallen below the 1,000 mark for the first time since the early ...
17h
A lawsuit filed over a brawl that broke out in a Little Rock restaurant in June 2020 that drew national attention and became ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.
Two new omicron subvariants have gained such prevalence in the U.S. that they now account for most of COVID-19 infections in ...
Friday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA (NASDAQ:SNY) for COVID-19 and ...
A new study reveals how COVID-19 vaccines prevent severe disease. This is based on research undertaken at the University of ...
The following is a summary of “BURDEN OF INFLAMMATORY BOWEL DISEASE ON COVID-19 HOSPITALIZATIONS: A NATIONWIDE ANALYSIS,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results